Your browser doesn't support javascript.
loading
Benefits and risks of low molecular weight heparin in patients with acute exacerbation of chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials.
Yang, Mingjin; Xu, Ying; Chen, Hong; Xu, Zhibo; Luo, Fengming.
Afiliação
  • Yang M; Respiratory Diseases Laboratory, Chengdu Second People's Hospital, No. 10, Qingyun South Street, Chengdu, 610017, China.
  • Xu Y; Respiratory Diseases Laboratory, Chengdu Second People's Hospital, No. 10, Qingyun South Street, Chengdu, 610017, China.
  • Chen H; Respiratory Diseases Laboratory, Chengdu Second People's Hospital, No. 10, Qingyun South Street, Chengdu, 610017, China.
  • Xu Z; Respiratory Diseases Laboratory, Chengdu Second People's Hospital, No. 10, Qingyun South Street, Chengdu, 610017, China. eyyhxyjs@126.com.
  • Luo F; Department of Pulmonary Diseases, West China Hospital, Sichuan University, Chengdu, China.
Inflammopharmacology ; 28(2): 451-462, 2020 Apr.
Article em En | MEDLINE | ID: mdl-31673891
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Heparina de Baixo Peso Molecular / Doença Pulmonar Obstrutiva Crônica / Anticoagulantes Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Heparina de Baixo Peso Molecular / Doença Pulmonar Obstrutiva Crônica / Anticoagulantes Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article